In addition, many studies have expanded the correlation between PDE4 and the pathogenesis of CNS diseases, demonstrating the beneficial effects of PDE4 inhibitors on CNS diseases such as stroke, Alzheimer’s disease, and depression (Richter et al., 2013; Blokland et al., 2019). This evidence concerns the gene PDE4A and major depressive disorder.